Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Royal Maxim Palace Kempinski

Oct 14, 2019 1:30 PM - Oct 15, 2019 11:30 PM

1st Settlement, Eastern Ring Road, New Cairo, 11477, Egypt

DIA Middle East Regulatory Conference (MERC)

The collaborative platform for connecting Regulatory experts in the Middle East

Session 6: Convergence and reliance for post-approval changes - where do we stand today?

Session Chair(s)

Susanne  Ausborn, PhD

Susanne Ausborn, PhD

Global Head International Regulatory Policy

Roche, Switzerland

This session will highlight the progress since the 2017 MERC and the publication of the EFPIA recommendations for ‘Optimising the management of Post-Approval Changes’, taking time to reflect on industry and Health Authority perspectives. Furthermore, the session will introduce the newly developed EFPIA position paper on managing post-approval safety labelling updates in the region with industry reflections on the challenges and opportunities that could be realised by global regulatory convergence and reliance.

Speaker(s)

Susanne  Ausborn, PhD

EFPIA LCM paper – what progress has been made?

Susanne Ausborn, PhD

Roche, Switzerland

Global Head International Regulatory Policy

Samvel  Azatyan, MD, PhD

Q&A and Panel Discussion, with the participation of:

Samvel Azatyan, MD, PhD

World Health Organization (WHO), Switzerland

Team Lead, Regulatory Convergence and Networks (RCN/REG)

Sabah  Memon

Sabah Memon

National Health Regulatory Authority (NHRA), Bahrain

Senior Pharmacist

Shereen  Abdel-Gaward

Shereen Abdel-Gaward

Egyptian Ministry of Health and Population, Egypt

Head of Central Administration of Pharmaceutical Care

Maha  Al Jaghbeer

Maha Al Jaghbeer

Jordan Food and Drug Administration, Jordan

Pharmacist, Head of Drug Registration Department

Bandar  Al Hammad, MPharm

Bandar Al Hammad, MPharm

Saudi Food and Drug Authority (SFDA), Saudi Arabia

Chief Pharmacist, Regulatory Affairs Department

Catherine  Al Ashram

Industry reflection on challenges with safety updates in the region

Catherine Al Ashram

Organon, Jordan

VP Regulatory Affairs & PV, Latin America MEA and Russia

Samvel  Azatyan, MD, PhD

Q&A and Panel Discussion, with the participation of:

Samvel Azatyan, MD, PhD

World Health Organization (WHO), Switzerland

Team Lead, Regulatory Convergence and Networks (RCN/REG)

Christina   Saad Khalil

Christina Saad Khalil

Egyptian Pharmaceutical Vigilance Center, Egypt

Pharmacovigilance Committee Rapporteur

Sarah  Al Maqseed

Sarah Al Maqseed

Ministry of Health, Kuwait, Kuwait

Registration and Release Superintendent

Sylvie  Meillerais, MSc

Sylvie Meillerais, MSc

Institut De Recherches Internationales Servier, France

Head of CMC Excellence

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.